About
ZiP Diagnostics is an Australian biotechnology company founded in 2019 and based in Collingwood, Victoria. The company specializes in developing and manufacturing rapid, high-performance, and low-cost point-of-care (POC) diagnostic tests for infectious diseases, catering to both human and animal health sectors. Operating under an ISO13485-compliant quality management system, ZiP Diagnostics ensures high standards in its production processes, with all significant components produced domestically in Australia. The company offers a range of rapid POC tests for various diseases, including respiratory, blood-borne, skin, sexually transmitted, and insect-borne diseases. Notably, they have developed the world’s first rapid POC test for scabies in collaboration with Menzies School of Health Research and Axxin Pty Ltd. Additionally, ZiP Diagnostics provides testing solutions for production and companion animals, helping manage endemic diseases and protect against potential threats to agriculture. Their partnerships with defence agencies focus on developing rapid tests for emerging diseases, emphasizing supply chain security in critical scenarios.
Technologies
Keywords
Company Information
- Employees27
- Founded2019
Location
Collingwood, Victoria, Australia, 3066